Krystal Biotech's top three insider shareholders as of March 23, 2026 are Dino A Rossi (Director, 78.69K shares), Kathryn Romano (Chief Accounting Officer, 22.37K shares), Andrew C. Orth (Chief Commercial Officer, 100 shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Dino A Rossi | 78,691 | 0 | 23 Feb, 2026 | |
| Kathryn Romano | Chief Accounting Officer | 22,366 | 0 | 03 Mar, 2026 |
| Andrew C. Orth | Chief Commercial Officer | 100 | 0 | 09 Jun, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 Feb, 2026 | Kathryn Romano | Common Stock | A | 7,500 | $0.00 | 26,068 | D | M |
| 27 Feb, 2026 | Kathryn Romano | Common Stock | D | 3,262 | $275.64 | 22,806 | D | F |
| 27 Feb, 2026 | Kathryn Romano | Common Stock | A | 550 | $0.00 | 23,356 | D | M |
| 27 Feb, 2026 | Kathryn Romano | Common Stock | D | 240 | $275.64 | 23,116 | D | F |
| 02 Mar, 2026 | Kathryn Romano | Common Stock | D | 750 | $267.60 | 22,366 | D | S |
| 27 Feb, 2026 | Kathryn Romano | Performance Stock Units | D | 7,500 | $0.00 | 0 | D | M |
| 27 Feb, 2026 | Kathryn Romano | Restricted Stock Units | D | 550 | $0.00 | 1,650 | D | M |
| 27 Feb, 2026 | Kathryn Romano | Stock Option (Right to Buy) | A | 13,575 | $0.00 | 13,575 | D | A |
| 27 Feb, 2026 | Kathryn Romano | Restricted Stock Units | A | 5,442 | $0.00 | 5,442 | D | A |
| 19 Feb, 2026 | Dino A Rossi | Common Stock | A | 18,950 | $8.79 | 97,641 | D | M |
| 19 Feb, 2026 | Dino A Rossi | Common Stock | D | 8,116 | $260.49 | 89,525 | D | S |
| 19 Feb, 2026 | Dino A Rossi | Common Stock | D | 10,834 | $262.10 | 78,691 | D | S |
| 19 Feb, 2026 | Dino A Rossi | Stock Option (Right to Buy) | D | 18,950 | $0.00 | 0 | D | M |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | A | 12,500 | $63.55 | 31,818 | D | M |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | D | 2,000 | $270.56 | 29,818 | D | S |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | D | 5,700 | $271.66 | 24,118 | D | S |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | D | 2,824 | $272.51 | 21,294 | D | S |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | D | 928 | $273.71 | 20,366 | D | S |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | D | 552 | $274.64 | 19,814 | D | S |
| 09 Feb, 2026 | Kathryn Romano | Common Stock | D | 400 | $275.68 | 19,414 | D | S |